Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates

分组1 - Qiagen reported quarterly earnings of $0.61 per share, exceeding the Zacks Consensus Estimate of $0.58 per share, and showing an increase from $0.59 per share a year ago, resulting in an earnings surprise of +5.17% [1] - The company achieved revenues of $532.58 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.25% and increasing from $501.87 million year-over-year [2] - Over the last four quarters, Qiagen has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] 分组2 - The stock has underperformed the market, losing about 0.3% since the beginning of the year, while the S&P 500 has gained 16.5% [3] - The current consensus EPS estimate for the upcoming quarter is $0.60 on revenues of $542.45 million, and for the current fiscal year, it is $2.34 on revenues of $2.09 billion [7] - The Medical - Biomedical and Genetics industry, to which Qiagen belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]